Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder.

Maremmani, Icro; Dematteis, Maurice; Gorzelanczyk, Edward J; Mugelli, Alessandro; Walcher, Stephan; Torrens, Marta.

Afiliação

Maremmani I; VP Dole Research Group, G. De Lisio Institute of Behavioural Sciences, Via di Pratale 3, 56121 Pisa, Italy.
Dematteis M; UniCamillus, International Medical University in Rome, Via di Sant'Alessandro 8, 00131 Rome, Italy.
Gorzelanczyk EJ; Department of Pharmacology and Addiction Medicine, Grenoble-Alpes University Hospital, Grenoble Alpes University, Rue de la Chantourne, 38043 Grenoble, France.
Mugelli A; Department of Theoretical Basis of Biomedical Sciences and Medical Informatics, Nicolaus Copernicus University, Collegium Medicum, 85-067 Bydgoszcz, Poland.
Walcher S; Faculty of Philosophy, Kazimierz Wielki University, 85-092 Bydgoszcz, Poland.
Torrens M; The Society for the Substitution Treatment of Addiction "Medically Assisted Recovery", 85-791 Bydgoszcz, Poland.

J Clin Med ; 12(17)2023 Aug 26.

Article em En | MEDLINE | ID: mdl-37685642